Sanofi

Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion

Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive

Its COVID-19 vaccine bogged down in trials, Sanofi to manufacture BioNTech/Pfizer doses

Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings

These four COVID-19 vaccines could soon join the pandemic fight